Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 224 of 1,261
  1. US 11510998

    Gene therapy for combined methylmalonic acidemia/aciduria and hyperhomocysteinemia/homocystinuria, cobalamin C type, and deficiency of MMACHC

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  2. US 11510984

    Anhydrous sodium thiosulfate and formulations thereof

    Fennec Pharmaceuticals, Inc. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  3. US 11510916

    Pharmaceutical compositions for intraocular administration and methods for fabricating thereof

    EYE CARE NORTHWEST, PA · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  4. US 11510927

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  5. US 11510872

    Nanoparticle-lipid composite carriers and uses thereof

    Northwestern University · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  6. US 11510904

    Methods of treating malignant lymphoproliferative disorders

    ACTUATE THERAPEUTICS INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  7. US 11510996

    Covalent polymer-antigen conjugated particles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  8. US 11512052

    Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

    United States Government as represented by the Department of Veterans Affairs · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  9. US 11512141

    Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatment

    The Board of Regents of the University of Texas System · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  10. US 11512110

    Targeted delivery system and methods of use therefor

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  11. US 11512327

    Compositions and methods for delivery of AAV

    VOYAGER THERAPEUTICS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  12. US 11512128

    VEGF/DLL4 binding agents and uses thereof

    MEREO BIOPHARMA 5, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  13. US 11510939

    RNAs for complement inhibition

    Apellis Pharmaceuticals, Inc. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  14. US 11512312

    Treatment of Fuchs' endothelial corneal dystrophy

    The Board of Regents of the University of Texas System · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  15. US 2022370646

    PHARMACEUTICAL COMPOSITIONS OF GD-BASED CONTRAST AGENTS

    BRACCO IMAGING SPA [IT] · Granted Nov 24, 2022 · Expires Nov 19, 2042

    granted
  16. CA 3217490

    MASITINIB POUR LE TRAITEMENT DU CANCER DE LA PROSTATE RESISTANT A LA CASTRATION

    AB SCIENCE [FR] · Granted Nov 24, 2022 · Expires Nov 19, 2042

    granted
  17. US 11505798

    Methods and compositions for treating inflammatory diseases

    The Regents of the University of California · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  18. US 11505790

    Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  19. US 11504325

    Micelles and vesicles for the delivery of glycopeptides

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  20. US 11504385

    Proteolysis targeting chimeric molecule, preparation method, and application

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  21. US 11505574

    Modulation of P53 for the treatment of cancer

    The Regents of the University of California · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  22. US 11505564

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  23. US 11505782

    Cell-based vehicles for potentiation of viral therapy

    Calidi Biotherapeutics, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  24. US 11505601

    Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serum

    Nanjing Legend Biotech Co., Ltd · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.